Objectives: Drug efflux pumps are one of the key machineries in bacterial drug resistance. Although quite a few of these transport systems have been functionally characterized in various organisms, due to large-scale genome sequencing efforts and improved prediction pipelines there are increasing numbers of putative drug efflux genes annotated. For phenotype identification of the proteins encoded by these genes, we developed a novel highthroughput phenotype screening strategy and demonstrated its utility in identifying phenotypes for putative efflux systems encoded by the human pathogen Acinetobacter baumannii.
Introduction
Drug efflux proteins are a major class of antimicrobial resistance determinants in MDR pathogens that mediate export of chemotherapeutic agents out of the cell. Efflux pumps act synergistically with other resistance determinants by lowering the intracellular concentrations of a drug to enable high-level drug resistance. In Gram-negative bacteria efflux pumps fall into one of six classes of transport proteins: the major facilitator superfamily (MFS); the ATP-binding cassette (ABC) superfamily; the resistance -nodulation -division (RND) family; the small multidrug resistance (SMR) family [a member of the much larger drug/ metabolite transporter (DMT) superfamily]; the multidrug and toxic compound extrusion (MATE) family; and the recently characterized proteobacterial antimicrobial compound efflux (PACE) transporter family.
1,2
Acinetobacter baumannii is a nosocomial Gram-negative pathogen that has become increasingly MDR in recent decades. 3 Various resistance mechanisms have been identified in this organism, including enzymatic drug degradation (e.g. b-lactamases inactivate b-lactam drugs such as ampicillin), genetic mutation of cellular targets (e.g. mutations in DNA topoisomerase genes result in ciprofloxacin resistance) and drug efflux. 4 The major drug efflux systems in A. baumannii are RND systems, of which the best characterized are AdeABC, AdeIJK and AdeFGH. 5 However, drug efflux pumps from other families have also been identified, including the MFS pumps CraA, Tet(B) and AmvA/AedF, the MATE family pump AbeM, the SMR family pump AbeS and the PACE family pump AceI. 2,6 -11 Next-generation genome sequencing technologies have enabled the identification of putative efflux proteins in bacteria. The genomes of .10 clinical MDR A. baumannii strains have been published and .1000 draft genome sequences are available for this organism. We have used the Transporter Automated Annotation Pipeline to predict the complete set of transport proteins encoded by A. baumannii (K. A. Hassan, L. D. H. Elbourne and I. T. Paulsen, unpublished results). 12, 13 These analyses have revealed that strains of A. baumannii typically contain .50 predicted drug efflux pumps, for which precise substrate specificities cannot be assigned without experimental data. However, traditional methods in efflux pump phenotype characterization are time consuming and labour intensive. To expedite analyses of efflux pumps of unknown function we have developed a multiplexed high-throughput phenotypic characterization platform and used it to assign drug resistance function to previously uncharacterized A. baumannii efflux pumps.
Materials and methods

Bacterial strains and growth conditions
A. baumannii strains ATCC 17978, 14 WM99c (GenBank accession number AERY01000087) and AYE 15 were used as the sources of chromosomal DNA. E. coli strains DH5a [supE44 DlacU169 (F80lacZDM15) hsdR17 recA1 endA1 gyrA96thi-1reA1] and AG100A [K-12 argE3 thi-1 rpsL xyl mtl D(gal-uvrB) DacrAB::Tn903 Kan r supE44] 16 were used as the heterologous expression hosts. The deletion mutant of the A1S_1535 homologue ACIAD_1873 17 present in Acinetobacter baylyi ADP1 was used for the confirmation of the resistance phenotype conferred by A1S_1535. A. baumannii and A. baylyi ADP1 cells were grown in LB broth or on LB agar plates under aerobic conditions at 378C. E. coli cells were grown in Mueller -Hinton (MH) broth or LB broth or on LB plates, supplemented with ampicillin (100 mg/L), under aerobic conditions at 378C.
Construction of plasmids carrying putative drug efflux genes
Fifteen putative drug efflux genes (Table 1) identified by TransAAP and two known drug transporters, tet(B) and craA (A1S_3146), were cloned into pTTQ18 18 and overexpressed in E. coli DH5a as described previously. Primers used for cloning are listed in Table S1 (available as Supplementary data at JAC Online). Briefly, genes were cloned into the pTTQ18 expression vector within the polylinker region downstream of the tac promoter. The genes were cloned in-frame to the endogenous start codon of pTTQ18 at their 5 ′ end and to a sequence encoding an RGSH6 tag at their 3 ′ end. The recombinant plasmids were then transformed into chemically competent E. coli DH5a cells (a-Select Chemically Competent Cells, Bioline) or chemically competent E. coli AG100A to assess resistance potential in a background lacking the major E. coli efflux pump AcrAB. Transformants were selected on LB plates containing 100 mg/L ampicillin. Sanger sequencing was used to confirm the accuracy of cloned gene products. Protein expression was detected using an anti-histidine antibody (RGS . His HRP Conjugate Kit, Qiagen) through western blotting.
Antimicrobial agents
The antimicrobial agents (Table 2) tested against E. coli DH5a, E. coli AG100A or the A. baylyi ADP1 ACIAD_1873 deletion mutant were purchased from Sigma, except for gentamicin, tetracycline and streptomycin, which were purchased from AMRESCO. 6 , amino acid sequence of arginine, glycine, serine and six histidine residues, which is a C-terminal tag of the insertion gene and serves as an epitope in western blotting.
Li et al. AMK, amikacin; GEN, gentamicin; KAN, kanamycin; TOB, tobramycin; STR, streptomycin; CAZ, ceftazidime; ERY, erythromycin; CIP, ciprofloxacin; NOR, norfloxacin; SUL, sulfamethoxazole; TMP, trimethoprim; TET, tetracycline; MIN, minocycline; CHL, chloramphenicol; TRC, triclosan; BEN, benzalkonium; CHO, chlorhexidine; MIT, mitomycin C; ACR, acriflavine; ETB, ethidium bromide; SFZ, sulfathiazole; PHE, 1,10-phenanthroline; DOX, doxycycline; FUS, fusidic acid. a The MIC values for E. coli clones with 2-fold higher resistance than the WT strain are presented in bold font. b Numbers presented are locus tags omitting the prefix ABAYE_ in the case of 0913 and A1S_ for the other numbers. c Multiplexed Biolog/qPCR identified sulfathiazole, 1,10-phenanthroline, doxycycline and fusidic acid as potential substrates of novel efflux pumps. Therefore, the respective E. coli clones' MICs were determined to validate the predictions generated by multiplexed Biolog/qPCR analysis.
Antimicrobial susceptibility testing
MIC analyses were conducted in MH broth using the 2-fold serial broth dilution method. 19 MH broth was supplemented with 0.05 mM IPTG for target membrane protein overexpression. At least three independent biological repeats were performed. Increased antimicrobial resistance levels were determined by comparison with the strain carrying empty pTTQ18 expression vector.
Multiplexed Biolog Phenotype Microarrays (PMs)
Biolog PM11-20 plates were used for phenotype screening. There are 240 antimicrobial agents on these plates, including antibiotics, antimetabolites, membrane-active agents, respiratory inhibitors and toxic metals. The multiplex Biolog PM assays were conducted by a variation of the manufacturer's protocol. 20 Glycerol stocks of E. coli DH5a cells harbouring pTTQ18-based transporter plasmids were streaked on LB plates containing 100 mg/L ampicillin and incubated at 378C overnight. A single colony of each clone was re-streaked on a fresh LB plate containing 100 mg/L ampicillin and again grown overnight at 378C. Colonies for each strain were resuspended in Biolog IF-0 solution to achieve 85% transmittance. One millilitre of each of the 17 experimental strains at 85% transmittance was mixed to obtain a 17 mL cell mixture. The mixture was diluted 200-fold in IF-10 (Biolog) supplemented with 1:100 dilution of dye A (Biolog) and 0.05 mM IPTG. One hundred microlitres of this cell suspension was then inoculated into each well of Biolog PM11-20 plates. A series of PM11-20 plates was prepared as a reference using the same method except only the parental strain, E. coli DH5a carrying pTTQ18, was used. All the plates were incubated in a Biolog OmniLog reader at 378C for 48 h. The data generated were analysed using Biolog OmniLog PM software to process, edit and compare cell respiration kinetic data of experimental samples and the reference.
The resistance phenotypes of novel drug transporter genes identified by a multiplexed Biolog and quantitative PCR (qPCR) screening method were confirmed by a standard Biolog assay. The procedure was the same as the multiplexed PM described previously, except that there was only one E. coli strain examined.
qPCR analysis
From the Biolog data, wells that showed a higher level of respiration on specific antimicrobial agents than the WT alone were selected for further characterization. Plasmid DNA was extracted from the cell mixtures in these wells of the Biolog plates using the Promega Wizard Plus SV Minipreps DNA Purification System. To determine which of the 17 strains was able to respire in the presence of the antimicrobial agent we employed a qPCR analysis to measure the relative abundance of each of the cloned genes. qPCR was performed as previously described using 17 sets of primers specifically targeting the putative drug efflux genes inserted into pTTQ18. 21 Control samples were prepared by replacing plasmid DNA with water (no signal detected). Primer amplification efficiency was tested to ensure all primers used in this study had an amplification efficiency between 90% and 110% (Table S2) .
Results
Putative drug efflux gene cloning
Seventeen A. baumannii efflux genes were cloned into the vector pTTQ18 (detailed gene information is shown in Table 1 ) and overexpressed in E. coli DH5a. Fifteen genes were putative drug efflux genes from the MFS and the ABC superfamily, identified using TransAAP, from A. baumannii ATCC 17978. One gene had been annotated as two ORFs (A1S_2311 and A1S_2312) due to an error in the ATCC 17978 genome sequence. The gene ABAYE_0913 was cloned from strain AYE, because its orthologue in ATCC 17978 has been disrupted by a transposon carrying a siderophore biosynthesis gene cluster. 22 The remaining two genes were positive controls with known functions, tet(B) encoding a tetracycline exporter and craA encoding a chloramphenicol exporter, cloned from A. baumannii WM99c and ATCC 17978, respectively. These two genes encode transporters from the MFS and these are likely to function as single-component pumps, similar to the novel pumps being tested. Western blots were used to determine the expression levels of the 17 cloned proteins. The expression of 15 of the target proteins was detected by western blotting, but two (A1S_1799 and A1S_2198) were undetectable ( Figure S1 ).
Drug resistance phenotypes of cloned efflux pumps by traditional MIC
The susceptibilities of these 17 E. coli clones to 20 compounds were tested using a traditional broth dilution MIC method ( Table 2 ). Consistent with their characterized substrates, cells expressing tet(B) showed increased MICs of tetracycline and minocycline, and the craA-expressing strain displayed a higher chloramphenicol MIC relative to the parental control. Both tet(B)-and craA-expressing cells also showed increased resistance to chlorhexidine, a biocide with a chemical structure very different from tetracycline drugs and chloramphenicol. In addition, we found that craA conferred resistance to mitomycin C with an 8-fold increase in resistance compared with the parental host. Among the 15 putative drug efflux pumps, only ABAYE_0913 showed a detectable phenotype, conferring resistance to mitomycin C (128-fold MIC increase), a potent DNA cross-linker antibiotic. Due to a concern that the major intrinsic MDR efflux pump AcrAB in the E. coli DH5a host might mask phenotypic changes caused by overexpression of these putative efflux pumps, the respective plasmids were transformed into an acrAB deletion strain of E. coli, AG100A, for further phenotype screening. All E. coli AG100A clones were screened using the same compounds as previously. In this analysis the craA and ABAYE_0913 clones displayed 8-fold and 4-fold increases, respectively, in tetraphenylphosphonium (TPP) resistance compared with the parental E. coli AG100A strain carrying the empty vector (Table S3 ). In contrast, expression of some of the heterologous proteins had a negative impact on the AG100A host strain's drug resistance level, lowering the MIC values. This may be due to the toxicity of overexpression of secondary membrane transport proteins in the E. coli inner membrane. 23 Multiplexed Biolog PMs and qPCR for high-throughput phenotype prediction
In order to find potential phenotypes for other transporters, the Biolog PM11-20 plates were used to screen the phenotypes of a pool of the 17 E. coli strains (Figure 1 ). In parallel, E. coli DH5a carrying the empty vector pTTQ18 was also screened using Biolog PM11-20 plates as a reference control. Each PM plate contained 24 compounds and each compound was present at four concentration gradients (Figure 2) . Differences in the respiration signal of the experimental pool compared with the reference control were determined from the relative heights of respiration curves.
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Cellular respiration is detected by the Biolog system using a redoxactive tetrazolium dye that undergoes a colorimetric change when reduced by the electrons generated during respiration. Therefore, any phenotypic difference from the Biolog analysis was assumed to be due to one or more resistant strains in the experimental pool. Total plasmids from these wells in the experimental plates were subsequently extracted for qPCR analysis. qPCR was used to determine the relative abundance of each of the 17 plasmids in the experimental pool, by targeting the putative drug efflux genes. Genes that showed a cycle threshold (Ct) value at least six cycles below the average of other plasmids (representing 64-fold higher abundance) in at least one antimicrobial condition were selected for further analysis. The level of drug resistance in these strains was then determined in isolation using MIC analyses.
Out of 240 antimicrobial resistance tests on the Biolog plates, we recorded 26 antibacterial phenotypic differences between the pool of strains expressing an A. baumannii efflux pump and the control (Figure 2) . Some of these differences corresponded to the known phenotypes conferred by Tet(B) and CraA, i.e. we observed a higher respiration signal on the Tet(B) substrates minocycline, demeclocycline, penimepicycline, doxycycline and oxytetracycline, and the CraA substrate chloramphenicol, suggesting that at least the positive control tet(B) and craA clones were among the resistant strains in these wells. Phenotypic differences were also recorded for five b-lactams, four aminoglycosides, two macrolides, three biocides, colistin, cinoxacin and five other antibacterials. Phenotypic differences were also recorded on several compounds not typically applied as antibacterials, including trifluorothymidine, sodium metasilicate and ruthenium red. To identify the strains responsible for these phenotypes and validate this method, total plasmids from the wells of 20 out of these 26 antibacterial compounds were purified and examined by qPCR.
The qPCR data for the 17 cloned drug efflux pump genes in the presence of the 20 antimicrobial compounds are presented as heat map in Figure 3 with the full dataset in Table S4 . Analysis of these data found that five different efflux genes were more abundant in one or more antimicrobial conditions compared with the background, suggesting that they confer resistance to these compounds. Two of these plasmids encoded the positive control proteins Tet(B) and CraA. As shown in Figure 3 , the Ct values of the tet(B) gene were much lower than background, indicating that tet(B) was the most abundant under the selection of minocycline, demeclocycline, doxycycline and oxytetracycline and showed a high abundance also with chlorhexidine selection. Similarly, craA Figure 1 . Schematic illustration of multiplexed Biolog/qPCR in high-throughput efflux pump phenotype screening. The same numbers of cells for each E. coli clone from the respective agar plates were resuspended and mixed in Biolog IF-10a solution (a -c) and the cell mixture was inoculated into Biolog PM11-20 plates (d), which were then incubated at 378C in a Biolog Omnilog machine (e), enabling simultaneous monitoring of cell respiration in the plate over 48 h. Afterwards, total plasmids were extracted directly from Biolog plates (f), where phenotypic changes were observed in comparison with the Biolog PM assay of E. coli carrying the empty pTTQ18 vector. In order to determine the most abundant plasmid(s), which may be responsible for the phenotypic change, the composition of total plasmids was analysed through qPCR (g) using drug transporter gene-specific primers. qPCR (h) is shown from PM20_F8, where tet(B) has a lower Ct value than the other genes, indicating E. coli expressing the Tet(B) protein is the most abundant clone in this well and is probably responsible for the increased oxytetracycline resistance phenotype.
Multiplexed assay identifies novel efflux pumps was found to be the most abundant determinant under the selection of chloramphenicol and chlorhexidine. In addition to tet(B) and craA, three genes, A1S_2795, ABAYE_0913 and A1S_1535, encoding putative drug efflux pumps, were highly abundant in the presence of various antimicrobials ( Figure 3 and Table S4 ). A1S_2795 and A1S_1535 were the most abundant under the selection of sulfathiazole and 1,10-phenanthroline (a peptidase inhibitor), respectively, whereas ABAYE_0913 was highly abundant under selection of both chloramphenicol and fusidic acid (Figure 3) . Several other antimicrobial conditions also showed higher respiration signals than the reference control. However, no clearly dominant strain(s) were identified in these wells. One possibility is that a number of the cloned efflux pumps may confer low-level resistance to these compounds and consequently no clearly dominant clone can be identified.
Conventional MIC confirmation of multiplexed Biolog/ qPCR results
To confirm the results of our high-throughput Biolog/qPCR method, we conducted MIC assays using 16 compounds identified by multiplex Biolog PM analysis as potential substrates of putative efflux pumps in this study (Figure 2 ).
In the previous MIC experiments the tet(B) clone showed increased levels of resistance to minocycline and chlorhexidine, and craA to chloramphenicol and chlorhexidine, consistent with the Biolog/qPCR results ( Table 3 ). The tet(B) clone was also much more resistant to doxycycline than E. coli carrying empty vector (Table 3) . Furthermore, the E. coli host gained higher resistance to sulfathiazole, chloramphenicol and 1,10-phenanthroline when overexpressing A1S_2795, ABAYE_0913 and A1S_1535, respectively (Table 3 ). These observations confirmed the predictions based on the qPCR analysis and demonstrated the capability of this novel multiplexed method for screening of the phenotypes of the putative drug exporters.
Because A1S_1535 represents the first ABC superfamily efflux pump in Acinetobacter to have a role in drug resistance, we sought additional functional evidence by examining a deletion mutant of the A. baylyi ADP1 orthologue. This mutant showed a 2-fold reduction in its MIC of 1,10-phenanthroline (6.25 mg/L) by comparison with WT (12.5 mg/L), providing confirmation of the function of this protein in its native host.
Resistance capability confirmed using single-plex Biolog PM assays
To determine whether phenotypes observed in the multiplexed Biolog assay are consistent with conventional Biolog PM assays, we conducted these assays on isolated strains expressing the A1S_2795, ABAYE_0913 and A1S_1535 genes ( Figure 4) . Consistent with the multiplexed Biolog/qPCR results, the isolated ABAYE_0913 E. coli clone was able to confer higher resistance levels than the control strain to chloramphenicol and fusidic acid, A1S_1535 to 1,10-phenanthroline and A1S_2795 to sulfathiazole.
As shown in Figure 4 , we detected additional resistance phenotypes for these genes when they were grown in isolation compared with the multiplexed screening method. For example, the putative ABC drug transporter A1S_1535 was also observed to confer resistance to another five antibiotics (gentamicin, kanamycin, chloramphenicol, D-cycloserine and oxytetracycline) and one biocide (chloroxylenol). The transporter encoded by A1S_1535 therefore is the first ABC drug resistance protein in A. baumannii to be phenotypically characterized.
The two novel MFS proteins encoded by ABAYE_0913 and A1S_2795 were found to share phenotypes by conventional Biolog PM experiments. These phenotypes include resistance to seven antibiotics (lincomycin, colistin, erythromycin, boric acid, chloramphenicol, oleandomycin and streptomycin) and one biocide (chloroxylenol). Resistance phenotypes for colistin, erythromycin, chloramphenicol and streptomycin had been previously examined using conventional MICs (Table 2) . However, except for the ABAYE_0913 E. coli clone, which showed a 2-fold MIC increase in chloramphenicol resistance, the other phenotypes were not observed for these two transporters by broth dilution MIC. Apart from their shared resistance phenotypes, the ABAYE_0913 drug transporter also confers resistance to four other antibiotics (fusidic acid, puromycin, cefotaxime and D-cycloserine) and two other biocides (dequalinium and cetylpyridinium). The A1S_2795 drug efflux pump showed additional resistance phenotypes, to sisomicin, sulfathiazole and geneticin. All these results demonstrated that both ORFs ABAYE_0913 and A1S_2795 encode novel multidrug resistance proteins belonging to the MFS transporter family.
Discussion
We demonstrated the capability of a combination of Biolog and qPCR as a novel multiplexed method for screening phenotypes for putative drug efflux proteins. In particular, its sensitivity in detecting the phenotypes of efflux pumps with clinical Multiplexed assay identifies novel efflux pumps significance, such as the two positive controls in our study [Tet(B) and CraA], showed its potential in screening or discovering other clinically significant drug exporters. Out of 15 ORFs encoding putative efflux proteins, three, A1S_1535, A1S_2795 and ABAYE_0913, were characterized as novel drug resistance genes. Of particular note, A1S_1535 is the first ABC drug resistance gene identified in A. baumannii. It confers resistance to 1,10-phenanthroline, gentamicin, kanamycin, chloramphenicol, oxytetracycline and chloroxylenol. The A1S_2795 protein is the first MFS drug resistance protein found to confer resistance to the sulphonamide sulfathiazole. The ABAYE_0913 protein had two drug resistance phenotypes detected by the Biolog/qPCR method: chloramphenicol and fusidic acid resistance. Single-plex Biolog PM assays further revealed that the two novel MFS proteins encoded by A1S_2795 and ABAYE_0913 have a broad drug resistance phenotype range.
The broad phenotypic screens applied in our method were successful in identifying novel resistance functions for efflux pumps thought to have a restricted substrate recognition profile. For example, Tet(B) and CraA had been previously characterized by traditional methods and thought to recognize tetracycline and chloramphenicol antibiotics. 6, 24 Our data indicated that these pumps probably have a broader spectrum of activity, since both pumps were found to be highly abundant within the chlorhexidine-containing wells of Biolog PM plates. Conventional MICs also confirmed that both of these pumps are able to confer resistance to this biocide. This phenotype is novel, particularly for Tet(B), which was the first identified bacterial drug efflux pump and is traditionally viewed as a substrate-specific efflux pump. 25 Recent studies of other tetracycline transporters, such as Tet38 from Staphylococcus aureus, have shown that it is able to transport Hoechst 33342, as well as fatty acids, which are likely to be its physiological substrates. 26 These data suggest that tetracycline transporters may have broader physiological functions than previously appreciated.
The multiplexed Biolog method is not solely based on antimicrobial selection but is also affected by competition between different E. coli clones. To investigate whether the three novel drug efflux pumps identified in this study might confer resistance to a broader range of compounds than those identified by conventional MIC or our Biolog/qPCR assay, we used Biolog PM11-20 plates to screen them individually. Overexpression of A1S_1535 was found to increase E. coli host resistance levels to oxytetracycline ( Figure 4) . However, the tet(B) plasmid was the only highly abundant plasmid for oxytetracycline in the multiplexed screening experiment (Figure 3) . The oxytetracycline resistance phenotype exhibited by A1S_1535 was probably masked by the strong growth and competition of the Tet(B)-expressing clone. In previous broth dilution MIC experiments no phenotypes were recorded for A1S_1535 resistance to gentamicin and kanamycin, whereas the Biolog assays suggested that overexpression of this protein can slightly increase the resistance of E. coli hosts to these two compounds. Additional phenotypes were also observed for the other two novel MFS proteins, which included potential phenotypes not identified by MIC, such as colistin and erythromycin (Figure 4 ). This suggests that conventional MIC analysis using 2-fold serial dilutions of the antimicrobial agent may be less sensitive than Biolog PM assays in identifying low-level drug resistance phenotypes of efflux pumps.
In comparison with traditional methods of drug efflux pump phenotype characterization, our method has a higher throughput and a significantly lower cost, and we were able to successfully screen 17 E. coli clones for resistance to 240 antimicrobial conditions, equivalent to conducting 4080 phenotypic tests simultaneously. In the next-generation sequencing era, there is an increased need for high-throughput methods of functional characterization for genes of unknown or only predicted function. Due to the functional redundancy of efflux pumps that recognize overlapping sets of substrates, gene knockout analyses of efflux pump genes often do not show as clear a phenotype as seen with heterologous overexpression studies. Thus, overexpression analysis in a susceptible background strain remains the easiest approach for identifying novel drug resistance factors in bacterial genomes. The multiplexed method in our study has the potential for higher throughput characterization of putative drug efflux pump phenotypes, not only in A. baumannii but also in other organisms.
